Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Berry anthocyanins and their aglycons inhibit monoamine oxidases A and B.

Dreiseitel A, Korte G, Schreier P, Oehme A, Locher S, Domani M, Hajak G, Sand PG.

Pharmacol Res. 2009 May;59(5):306-11. doi: 10.1016/j.phrs.2009.01.014.

PMID:
19416630
2.
3.

Selective MAO-B inhibitors: a lesson from natural products.

Carradori S, D'Ascenzio M, Chimenti P, Secci D, Bolasco A.

Mol Divers. 2014 Feb;18(1):219-43. doi: 10.1007/s11030-013-9490-6. Review.

PMID:
24218136
4.

Inhibition of human monoamine oxidase A and B by 5-phenoxy 8-aminoquinoline analogs.

Chaurasiya ND, Ganesan S, Nanayakkara NP, Dias LR, Walker LA, Tekwani BL.

Bioorg Med Chem Lett. 2012 Feb 15;22(4):1701-4. doi: 10.1016/j.bmcl.2011.12.108.

PMID:
22264472
5.
6.

Inhibition of proteasome activity by anthocyanins and anthocyanidins.

Dreiseitel A, Schreier P, Oehme A, Locher S, Rogler G, Piberger H, Hajak G, Sand PG.

Biochem Biophys Res Commun. 2008 Jul 18;372(1):57-61. doi: 10.1016/j.bbrc.2008.04.140.

PMID:
18460339
8.

Structure-based design and analysis of MAO-B inhibitors for Parkinson's disease: using in silico approaches.

Kare P, Bhat J, Sobhia ME.

Mol Divers. 2013 Feb;17(1):111-22. doi: 10.1007/s11030-012-9420-z.

PMID:
23325357
9.

Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.

J Med Chem. 2008 Nov 13;51(21):6740-51. doi: 10.1021/jm800656v.

PMID:
18834112
10.

Novel sulfanylphthalimide analogues as highly potent inhibitors of monoamine oxidase B.

Van der Walt MM, Terre'Blanche G, Petzer A, Petzer JP.

Bioorg Med Chem Lett. 2012 Nov 1;22(21):6632-5. doi: 10.1016/j.bmcl.2012.08.113.

PMID:
23010267
11.

Lights and shadows on monoamine oxidase inhibition in neuroprotective pharmacological therapies.

Binda C, Milczek EM, Bonivento D, Wang J, Mattevi A, Edmondson DE.

Curr Top Med Chem. 2011 Nov;11(22):2788-96. Review.

PMID:
22039878
12.
13.

1-methyl-2-undecyl-4(1H)-quinolone as an irreversible and selective inhibitor of type B monoamine oxidase.

Lee MK, Hwang BY, Lee SA, Oh GJ, Choi WH, Hong SS, Lee KS, Ro JS.

Chem Pharm Bull (Tokyo). 2003 Apr;51(4):409-11.

14.

In vitro inhibition of cytochrome P450 3A4 by Aronia melanocarpa constituents.

Bräunlich M, Christensen H, Johannesen S, Slimestad R, Wangensteen H, Malterud KE, Barsett H.

Planta Med. 2013 Jan;79(2):137-41. doi: 10.1055/s-0032-1328055.

PMID:
23250807
15.

Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.

Bonaiuto E, Milelli A, Cozza G, Tumiatti V, Marchetti C, Agostinelli E, Fimognari C, Hrelia P, Minarini A, Di Paolo ML.

Eur J Med Chem. 2013;70:88-101. doi: 10.1016/j.ejmech.2013.07.005.

PMID:
24140951
16.
18.

Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.

Gaspar A, Reis J, Fonseca A, Milhazes N, Viña D, Uriarte E, Borges F.

Bioorg Med Chem Lett. 2011 Jan 15;21(2):707-9. doi: 10.1016/j.bmcl.2010.11.128.

PMID:
21194943
19.

In vitro inhibition of phenolsulphotransferase by food and drink constituents.

Gibb C, Glover V, Sandler M.

Biochem Pharmacol. 1987 Jul 15;36(14):2325-30.

PMID:
3475069
20.

Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits.

Jayaprakasam B, Vareed SK, Olson LK, Nair MG.

J Agric Food Chem. 2005 Jan 12;53(1):28-31.

PMID:
15631504
Items per page

Supplemental Content

Support Center